This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
quadgram | frequency |
---|---|
severe acute respiratory syndrome | 2764 |
acute respiratory syndrome coronavirus | 1528 |
middle east respiratory syndrome | 1237 |
east respiratory syndrome coronavirus | 951 |
of severe acute respiratory | 835 |
for the treatment of | 433 |
a l p r | 387 |
p r o o | 387 |
l p r e | 387 |
u r n a | 387 |
n a l p | 387 |
r o o f | 387 |
j o u r | 387 |
r n a l | 387 |
o u r n | 387 |
acute respiratory distress syndrome | 380 |
in patients with covid | 355 |
of middle east respiratory | 325 |
the severe acute respiratory | 300 |
with severe acute respiratory | 284 |
in the treatment of | 251 |
respiratory syndrome coronavirus infection | 233 |
in patients with severe | 220 |
on the other hand | 216 |
in the united states | 211 |
of patients infected with | 208 |
of a novel coronavirus | 198 |
in the absence of | 192 |
the treatment of covid | 185 |
a novel coronavirus from | 182 |
who has granted medrxiv | 181 |
display the preprint in | 181 |
medrxiv a license to | 181 |
license to display the | 181 |
has granted medrxiv a | 181 |
a license to display | 181 |
to display the preprint | 181 |
granted medrxiv a license | 181 |
in the context of | 178 |
disease control and prevention | 178 |
in the case of | 173 |
for disease control and | 172 |
the copyright holder for | 169 |
copyright holder for this | 169 |
of the novel coronavirus | 166 |
for the development of | 165 |
of hospitalized patients with | 160 |
is the author funder | 160 |
for the detection of | 160 |
the world health organization | 156 |
is protected by copyright | 155 |
this article is protected | 155 |
article is protected by | 155 |
patients with coronavirus disease | 152 |
at the time of | 151 |
critically ill patients with | 148 |
systematic review and meta | 146 |
as well as the | 145 |
a systematic review and | 143 |
clinical features of patients | 143 |
of the s protein | 142 |
patients with severe acute | 141 |
the middle east respiratory | 140 |
it is important to | 140 |
infected with novel coronavirus | 139 |
the spike protein of | 139 |
certified by peer review | 139 |
of the spike protein | 138 |
not certified by peer | 138 |
with novel coronavirus in | 137 |
has been shown to | 137 |
patients infected with novel | 137 |
was not certified by | 137 |
features of patients infected | 136 |
patients with severe covid | 136 |
with a new coronavirus | 135 |
patients infected with sars | 133 |
a pneumonia outbreak associated | 131 |
a new coronavirus of | 131 |
coronavirus of probable bat | 131 |
pneumonia outbreak associated with | 131 |
from patients with pneumonia | 131 |
associated with a new | 131 |
outbreak associated with a | 131 |
new coronavirus of probable | 131 |
of probable bat origin | 131 |
which was not certified | 124 |
on ace and tmprss | 124 |
depends on ace and | 124 |
cell entry depends on | 124 |
ace and tmprss and | 123 |
entry depends on ace | 123 |
is blocked by a | 123 |
blocked by a clinically | 122 |
and is blocked by | 122 |
by a clinically proven | 122 |
of patients with covid | 122 |
novel coronavirus in wuhan | 122 |
novel coronavirus from patients | 121 |
of novel coronavirus pneumonia | 121 |
coronavirus from patients with | 121 |
a clinically proven protease | 121 |
and tmprss and is | 121 |
respiratory syndrome coronavirus in | 120 |
clinically proven protease inhibitor | 120 |
tmprss and is blocked | 120 |
with pneumonia in china | 120 |
patients with pneumonia in | 120 |
spike protein of sars | 118 |
was found to be | 118 |
hospitalized patients with covid | 116 |
the presence of sars | 115 |
the detection of sars | 114 |
and clinical characteristics of | 113 |
in vitro and in | 109 |
patients with novel coronavirus | 109 |
of critically ill patients | 109 |
the preprint in perpetuity | 107 |
after the onset of | 107 |
as a result of | 106 |
for severe acute respiratory | 106 |
with acute respiratory distress | 104 |
is one of the | 103 |
have been shown to | 103 |
by severe acute respiratory | 102 |
in the presence of | 101 |
of the severe acute | 100 |
the treatment of sars | 100 |
respiratory syndrome coronavirus spike | 100 |
the onset of symptoms | 99 |
an important role in | 99 |
on the surface of | 97 |
s protein of sars | 96 |
of the sars coronavirus | 96 |
characteristics of cases of | 96 |
in patients with sars | 96 |
the s protein of | 95 |
clinical characteristics of cases | 94 |
and epidemiology of novel | 94 |
for virus origins and | 94 |
implications for virus origins | 94 |
were found to be | 94 |
epidemiology of novel coronavirus | 94 |
origins and receptor binding | 93 |
virus origins and receptor | 93 |
holder for this preprint | 92 |
a functional receptor for | 92 |
antibody responses to sars | 92 |
in vero e cells | 92 |
genomic characterisation and epidemiology | 91 |
in addition to the | 91 |
characterisation and epidemiology of | 91 |
detection of novel coronavirus | 91 |
a retrospective cohort study | 91 |
with the novel coronavirus | 90 |
vitro and in vivo | 89 |
centers for disease control | 89 |
em structure of the | 89 |
structure of the sars | 89 |
human respiratory disease in | 88 |
the central nervous system | 87 |
a new coronavirus associated | 86 |
respiratory disease in china | 86 |
coronavirus associated with human | 86 |
with human respiratory disease | 86 |
associated with human respiratory | 86 |
new coronavirus associated with | 86 |
of the virus in | 85 |
the spread of the | 84 |
of novel coronavirus in | 84 |
one of the most | 83 |
center for disease control | 83 |
in severe acute respiratory | 83 |
is a functional receptor | 83 |
epidemiological and clinical characteristics | 82 |
novel coronavirus pneumonia in | 82 |
functional receptor for the | 82 |
on the basis of | 81 |
cases of novel coronavirus | 81 |
a wide range of | 81 |
acute respiratory syndrome in | 80 |
of coronavirus disease in | 80 |
of cases of novel | 79 |
syndrome coronavirus spike protein | 79 |
and middle east respiratory | 78 |
entry into host cells | 78 |
the novel coronavirus from | 78 |
holder for this this | 77 |
studies have shown that | 77 |
for this this version | 77 |
in the respiratory tract | 77 |
in the prefusion conformation | 77 |
this this version posted | 77 |
coronavirus pneumonia in wuhan | 76 |
play a role in | 76 |
license it is made | 75 |
antigenicity of the sars | 75 |
the upper respiratory tract | 75 |
hospitalized patients with novel | 75 |
it is made available | 75 |
international license it is | 75 |
is made available under | 75 |
efficacy and safety of | 75 |
associated with acute respiratory | 75 |
of the immune system | 75 |
made available under a | 75 |
in the spike protein | 74 |
spread of the virus | 74 |
spike in the prefusion | 74 |
in the development of | 73 |
isolation and characterization of | 73 |
structural studies of sars | 73 |
a large number of | 73 |
and antigenicity of the | 73 |
ncov spike in the | 73 |
in the lungs of | 72 |
of convalescent plasma therapy | 72 |
can be used to | 72 |
associated with the novel | 72 |
been shown to be | 71 |
an analysis based on | 71 |
effectively inhibit the recently | 70 |
chloroquine effectively inhibit the | 70 |
the recently emerged novel | 70 |
inhibit the recently emerged | 70 |
a familial cluster of | 70 |
the novel coronavirus indicating | 69 |
remdesivir and chloroquine effectively | 69 |
novel coronavirus from wuhan | 69 |
recently emerged novel coronavirus | 69 |
and chloroquine effectively inhibit | 69 |
characteristics of coronavirus disease | 69 |
the receptor binding domain | 69 |
it is possible that | 69 |
coronavirus disease in china | 69 |
no conflict of interest | 69 |
preprint this version posted | 68 |
cd and cd t | 68 |
this preprint this version | 68 |
at the end of | 68 |
for this preprint this | 68 |
characteristics of hospitalized patients | 67 |
analysis based on decade | 67 |
for middle east respiratory | 67 |
the spike glycoprotein of | 67 |
preprint the copyright holder | 67 |
associated with severe acute | 67 |
clinical characteristics of hospitalized | 67 |
a study of a | 67 |
clinical characteristics of coronavirus | 67 |
transmission dynamics in wuhan | 66 |
prevention and treatment of | 66 |
in the setting of | 66 |
identification of a novel | 66 |
in the pathogenesis of | 66 |
the treatment of severe | 66 |
pneumonia associated with the | 66 |
of the virus to | 66 |
early transmission dynamics in | 66 |
of pneumonia associated with | 66 |
tested positive for sars | 66 |
familial cluster of pneumonia | 65 |
long structural studies of | 65 |
in hospitalized patients with | 65 |
food and drug administration | 65 |
novel coronavirus associated with | 65 |
the authors declare no | 65 |
a novel coronavirus associated | 65 |
the authors declare that | 65 |
of the virus and | 65 |
the lower respiratory tract | 65 |
cluster of pneumonia associated | 64 |
study of a family | 64 |
transmission of the virus | 64 |
of patients with sars | 64 |
of a family cluster | 64 |
by the novel coronavirus | 63 |
the end of the | 63 |
novel coronavirus in the | 62 |
a report of cases | 62 |
case of novel coronavirus | 61 |
coronavirus associated with severe | 61 |
to severe acute respiratory | 61 |
into the host cell | 61 |
at the same time | 61 |
novel coronavirus from a | 60 |
to the ace receptor | 60 |
this version posted september | 60 |
a systematic review of | 60 |
infected pneumonia in wuhan | 60 |
the efficacy and safety | 59 |
days after the onset | 59 |
for the presence of | 59 |
coronavirus in the united | 59 |
a novel coronavirus in | 59 |
the surface of the | 59 |
chinese center for disease | 58 |
the intensive care unit | 58 |
crystal structure of sars | 58 |
treatment of severe acute | 58 |
with middle east respiratory | 58 |
isolation of a novel | 58 |
novel coronavirus indicating person | 58 |
as well as in | 58 |
for the diagnosis of | 58 |
an observational cohort study | 58 |
first case of novel | 58 |
of the middle east | 58 |
during the course of | 57 |
coronavirus in patients with | 57 |
the beginning of the | 57 |
the presence of the | 57 |
there is no evidence | 57 |
structural basis for the | 57 |
the development of a | 57 |
a key role in | 56 |
pneumonia in saudi arabia | 56 |
cause of severe acute | 56 |
with pneumonia in saudi | 56 |
species severe acute respiratory | 56 |
by the world health | 56 |
to the development of | 56 |
a man with pneumonia | 56 |
similar to that of | 56 |
from a man with | 56 |
coronavirus from a man | 56 |
man with pneumonia in | 56 |
in critically ill patients | 56 |
committee on taxonomy of | 55 |
as shown in figure | 55 |
international committee on taxonomy | 55 |
pp a and pp | 55 |
the severity of the | 55 |
origin and evolution of | 55 |
the species severe acute | 54 |
the crystal structure of | 54 |
the active site of | 54 |
the international committee on | 54 |
the early stage of | 54 |
ill patients with covid | 54 |
of the coronavirus disease | 53 |
ill patients with sars | 53 |
the spread of sars | 53 |
ncov and naming it | 53 |
the course of the | 53 |
the incubation period of | 53 |
and naming it sars | 53 |
it was found that | 52 |
entry into the host | 52 |
functional receptor for sars | 52 |
recognition by the novel | 52 |
the virus in the | 52 |
receptor recognition by the | 52 |
the early stages of | 52 |
has been reported to | 52 |
the prevention and treatment | 51 |
the s protein is | 51 |
it has been shown | 51 |
the causative agent of | 51 |
that they have no | 51 |
a better understanding of | 51 |
the spread of covid | 51 |
studies of sars coronavirus | 51 |
the entry of sars | 50 |
of angiotensin converting enzyme | 50 |
play an important role | 50 |
in different types of | 50 |
types of clinical specimens | 50 |
convalescent plasma therapy in | 50 |
studies are needed to | 49 |
of viral rna in | 49 |
the diagnosis of covid | 49 |
in patients infected with | 49 |
and cd t cells | 49 |
the s subunit of | 49 |
declare that they have | 49 |
basis for design of | 49 |
different types of clinical | 49 |
a and pp ab | 49 |
isolated from a patient | 49 |
orf a and orf | 49 |
receptor for the sars | 49 |
coronavirus spike protein by | 49 |
to that of sars | 49 |
has been reported in | 48 |
spike glycoprotein of sars | 48 |
virological assessment of hospitalized | 48 |
in a patient with | 48 |
and risk factors for | 48 |
the pathogenesis of sars | 48 |
in patients with coronavirus | 48 |
the total number of | 48 |
the role of the | 48 |
and evolution of pathogenic | 48 |
the case of sars | 48 |
evolution of pathogenic coronaviruses | 48 |
safety and immunogenicity of | 48 |
the treatment of patients | 47 |
an increased risk of | 47 |
the proximal origin of | 47 |
entry of the virus | 47 |
the chinese center for | 47 |
it should be noted | 47 |
in accordance with the | 47 |
in the present study | 47 |
use of convalescent plasma | 47 |
enzyme is a functional | 47 |
increase the risk of | 46 |
in adults hospitalized with | 46 |
for the sars coronavirus | 46 |
the d g mutation | 46 |
and treatment of covid | 46 |
transcription polymerase chain reaction | 46 |
on taxonomy of viruses | 46 |
novel coronavirus in patients | 46 |
assessment of hospitalized patients | 46 |
a role in the | 46 |
proximal origin of sars | 46 |
for the recognition of | 46 |
the replication of sars | 46 |
of novel coronavirus disease | 45 |
the emergence of sars | 45 |
authors declare that they | 45 |
it is likely that | 45 |
human airway epithelial cells | 45 |
important to note that | 45 |
risk factors for mortality | 45 |
is important to note | 45 |
binding domain complexed with | 45 |
is responsible for the | 45 |
immune response to sars | 45 |
the presence of a | 45 |
in the s protein | 45 |
hospitalized with severe covid | 45 |
a higher risk of | 45 |
as compared with sars | 45 |
outcomes of critically ill | 45 |
for the prevention and | 45 |
remains neutral with regard | 44 |
for the management of | 44 |
adults hospitalized with severe | 44 |
with regard to jurisdictional | 44 |
a is the author | 44 |
available under a is | 44 |
springer nature remains neutral | 44 |
to be associated with | 44 |
have been reported in | 44 |
jurisdictional claims in published | 44 |
in published maps and | 44 |
should be noted that | 44 |
regard to jurisdictional claims | 44 |
claims in published maps | 44 |
outbreak of severe acute | 44 |
neutral with regard to | 44 |
days after symptom onset | 44 |
maps and institutional affiliations | 44 |
nature remains neutral with | 44 |
under a is the | 44 |
published maps and institutional | 44 |
to jurisdictional claims in | 44 |
the transmission of sars | 44 |
the risk of sars | 44 |
reduce the risk of | 43 |
treatment of patients with | 43 |
diagnosis and treatment of | 43 |
and severe acute respiratory | 43 |
inflammatory cytokines and chemokines | 43 |
and outcomes of critically | 43 |
mechanism of action of | 43 |
and surface stability of | 43 |
from a patient with | 43 |
coronavirus isolated from a | 43 |
aerosol and surface stability | 43 |
of coronavirus spike proteins | 43 |
of the novel human | 43 |
composition and divergence of | 43 |
the origin of sars | 43 |
cytokine storm syndromes and | 42 |
of the ace receptor | 42 |
from the chinese center | 42 |
consider cytokine storm syndromes | 42 |
related to the sars | 42 |
with novel coronavirus pneumonia | 42 |
declare no conflict of | 42 |
note springer nature remains | 42 |
authors declare no conflict | 42 |
in the number of | 42 |
cases from the chinese | 42 |
caused by severe acute | 42 |
surface stability of sars | 41 |
characteristics of and important | 41 |
important lessons from the | 41 |
a randomized clinical trial | 41 |
converting enzyme is a | 41 |
has been shown that | 41 |
in balb c mice | 41 |
on the use of | 41 |
respiratory syndrome coronavirus and | 41 |
the functional receptor for | 41 |
in the upper respiratory | 41 |
a trial of lopinavir | 41 |
would like to thank | 41 |
storm syndromes and immunosuppression | 41 |
of and important lessons | 41 |
born to mothers with | 41 |
syndrome coronavirus infection in | 41 |
have been reported to | 41 |
of the new coronavirus | 41 |
and important lessons from | 41 |
lessons from the coronavirus | 40 |
basis for the recognition | 40 |
in the human population | 40 |
has been detected in | 40 |
all over the world | 40 |
national institutes of health | 40 |
of the viral genome | 40 |
igm and igg antibodies | 40 |
specimens of infected patients | 40 |
a potent inhibitor of | 40 |
of cases from the | 40 |
important role in the | 40 |
it has been reported | 40 |
of a report of | 40 |
from the coronavirus disease | 40 |
in upper respiratory specimens | 40 |
we would like to | 40 |
by the severe acute | 40 |
in human airway epithelial | 40 |
upper respiratory specimens of | 40 |
summary of a report | 40 |
the rest of the | 40 |
respiratory specimens of infected | 40 |
be used as a | 40 |
peripheral blood mononuclear cells | 40 |
with a history of | 40 |
insights into emerging coronaviruses | 39 |
clinical course and risk | 39 |
the outbreak of sars | 39 |
and azithromycin as a | 39 |
in vitro antiviral activity | 39 |
load in upper respiratory | 39 |
to the lack of | 39 |
rna was detected in | 39 |
the majority of the | 39 |
spike glycoprotein of the | 39 |
plays an important role | 39 |
viral load in upper | 39 |
have been associated with | 39 |
the development of vaccines | 39 |
has the potential to | 39 |
as one of the | 39 |
binding domain of the | 39 |
report of cases from | 39 |
clinical course and outcomes | 39 |
a risk factor for | 39 |
recent insights into emerging | 39 |
pathological findings of covid | 39 |
x x x x | 39 |
for treatment of covid | 39 |
effectiveness of convalescent plasma | 39 |
can be detected in | 39 |
course and outcomes of | 39 |
course and risk factors | 39 |
treatment of novel coronavirus | 39 |
can be found in | 39 |
factors for mortality of | 39 |
for mortality of adult | 39 |
hydroxychloroquine and azithromycin as | 39 |
for the novel coronavirus | 39 |
the results of the | 39 |
with the exception of | 38 |
crystal structure of the | 38 |
receptor for sars coronavirus | 38 |
with the use of | 38 |
and pathogenesis of coronaviruses | 38 |
of patients with severe | 38 |
the rapid spread of | 38 |
of the virus into | 38 |
it was shown that | 38 |
a and orf b | 38 |
used in this study | 38 |
adult inpatients with covid | 38 |
ritonavir in adults hospitalized | 38 |
of adult inpatients with | 38 |
a critical role in | 38 |
in the course of | 38 |
was detected in the | 38 |
patients with middle east | 38 |
outbreak of novel coronavirus | 38 |
results of an open | 38 |
azithromycin as a treatment | 38 |
safety and efficacy of | 38 |
at the beginning of | 38 |
mortality of adult inpatients | 38 |
has been associated with | 37 |
response in patients with | 37 |
s and s subunits | 37 |
hydroxychloroquine for the treatment | 37 |
was approved by the | 37 |
as a treatment of | 37 |
a first step in | 37 |
global initiative on sharing | 37 |
these results suggest that | 37 |
tissue distribution of ace | 37 |
inhibits the replication of | 37 |
chronic obstructive pulmonary disease | 37 |
specific human monoclonal antibody | 37 |
a treatment of covid | 37 |
the context of the | 36 |
the respiratory tract of | 36 |
in the early stage | 36 |
to the sars coronavirus | 36 |
the epithelial cells of | 36 |
the pathogenesis of covid | 36 |
type i and type | 36 |
of viruses related to | 36 |
at the s s | 36 |
upper and lower respiratory | 36 |
the innate immune response | 36 |
of viral load in | 36 |
a human monoclonal antibody | 36 |
to the host cell | 36 |
the genome sequence of | 36 |
as well as a | 35 |
m a n u | 35 |
discovery and therapeutic options | 35 |
the first case of | 35 |
n u s c | 35 |
of the international committee | 35 |
cov cl pro and | 35 |
against severe acute respiratory | 35 |
dependent rna polymerase from | 35 |
the sars coronavirus from | 35 |
patient with atypical pneumonia | 35 |
receptor recognition by sars | 35 |
c r i p | 35 |
coronavirus from animals in | 35 |
the host cell membrane | 35 |
a n u s | 35 |
u s c r | 35 |
pneumonia after visiting wuhan | 35 |
r i p t | 35 |
s c r i | 35 |
from animals in southern | 35 |
are more likely to | 35 |
treatment of middle east | 35 |
genomic characterization of the | 35 |
characterization of the novel | 35 |
viruses related to the | 35 |
the binding of the | 35 |
animals in southern china | 35 |
with atypical pneumonia after | 35 |
a member of the | 35 |
a patient with atypical | 35 |
sars coronavirus from animals | 35 |
a crucial role in | 35 |
the centers for disease | 35 |
atypical pneumonia after visiting | 35 |
syndrome in hong kong | 34 |
to the presence of | 34 |
cell entry and receptor | 34 |
neutralizing antibodies against sars | 34 |
basis of receptor recognition | 34 |
of receptor recognition by | 34 |
of the immune response | 34 |
been reported to be | 34 |
is mediated by the | 34 |
and characterization of viruses | 34 |
inflammatory syndrome in children | 34 |
there is an urgent | 34 |
multisystem inflammatory syndrome in | 34 |
respiratory syndrome in hong | 34 |
initiative on sharing all | 34 |
is likely to be | 34 |
first step in understanding | 34 |
structural basis of receptor | 34 |
may play a role | 34 |
outcomes of patients with | 34 |
distribution of ace protein | 34 |
characterization of viruses related | 34 |
this work was supported | 34 |
for the first time | 34 |
spike protein by a | 34 |
due to the lack | 34 |
infection from an asymptomatic | 34 |
innate and adaptive immune | 34 |
and the presence of | 34 |
the antiviral activity of | 34 |
is consistent with the | 34 |
sars cov m pro | 34 |
the sars coronavirus spike | 34 |
and characterization of a | 34 |
caused by a novel | 34 |
against middle east respiratory | 34 |
of spike glycoprotein of | 33 |
protein by a sars | 33 |
peptidase is a functional | 33 |
the emerging human coronavirus | 33 |
a nonhuman primate model | 33 |
and other domesticated animals | 33 |
of cell entry and | 33 |
assessment of cell entry | 33 |
the development of new | 33 |
and approved the final | 33 |
by the presence of | 33 |
of sars coronavirus spike | 33 |
for the emerging human | 33 |
in the management of | 33 |
novel coronavirus spike protein | 33 |
receptor for the emerging | 33 |
step in understanding sars | 33 |
evolution of the novel | 33 |
on sharing all influenza | 33 |
respiratory distress syndrome and | 33 |
host response to sars | 33 |
in a nonhuman primate | 33 |
studies are required to | 33 |
the expression of ace | 33 |
dipeptidyl peptidase is a | 33 |
entry and receptor usage | 33 |
in understanding sars pathogenesis | 33 |
functional assessment of cell | 33 |
presence or absence of | 33 |
in response to the | 33 |
may be due to | 33 |
as severe acute respiratory | 33 |
has been reported that | 33 |
binding domain bound to | 33 |
binding of novel coronavirus | 33 |
or in combination with | 33 |
to better understand the | 33 |
and receptor usage for | 33 |
of t cell responses | 33 |
the diagnosis of sars | 33 |
work was supported by | 33 |
mortality in patients with | 32 |
pathogenic coronavirus isolated from | 32 |
a single dose of | 32 |
was shown to be | 32 |
of a patient with | 32 |
a novel human coronavirus | 32 |
potent binding of novel | 32 |
ncov infection from an | 32 |
as well as to | 32 |
is based on the | 32 |
a patient with covid | 32 |
of novel coronavirus spike | 32 |
was supported by the | 32 |
a review of the | 32 |
better understanding of the | 32 |
who have recovered from | 32 |
drug discovery and therapeutic | 32 |
is an urgent need | 32 |
viral load in a | 32 |
entry and its immune | 32 |
the immune response to | 32 |
to the intensive care | 32 |
characterization of spike glycoprotein | 32 |
prevent the spread of | 32 |
from an asymptomatic contact | 32 |
it is necessary to | 32 |
domain bound to the | 32 |
of the s subunit | 32 |
cov infection in a | 32 |
of acute respiratory distress | 32 |
on virus entry and | 32 |
the acute phase of | 32 |
asymptomatic contact in germany | 32 |
respiratory distress syndrome in | 32 |
in close contact with | 32 |
an asymptomatic contact in | 32 |
virus entry and its | 32 |
sharing all influenza data | 32 |
other domesticated animals to | 32 |
of the same clade | 32 |
optimized dosing design of | 31 |
glycoprotein of the new | 31 |
of hydroxychloroquine for the | 31 |
of allergy and infectious | 31 |
of the virus from | 31 |
treatment of critically ill | 31 |
neurological manifestations of covid | 31 |
bound to the ace | 31 |
in a mouse model | 31 |
prevention and control of | 31 |
the creative commons attribution | 31 |
detection of severe acute | 31 |
and cellular immune responses | 31 |
absent in cov of | 31 |
hospitalized patients with coronavirus | 31 |
by a novel coronavirus | 31 |
in a recent study | 31 |
this is the first | 31 |
a case report of | 31 |
of the creative commons | 31 |
viral load of sars | 31 |
site absent in cov | 31 |
design of hydroxychloroquine for | 31 |
a final concentration of | 31 |
in cov of the | 31 |
activity and projection of | 31 |
the use of corticosteroids | 31 |
the neuroinvasive potential of | 31 |
characterization of a novel | 31 |
the detection of the | 31 |
higher than that of | 31 |
be related to the | 31 |
the s protein and | 31 |
and projection of optimized | 31 |
acute respiratory syndrome a | 31 |
and its immune cross | 31 |
respiratory syndrome coronavirus replication | 31 |
of optimized dosing design | 31 |
treatment of severe covid | 31 |
provides a basis for | 31 |
projection of optimized dosing | 31 |
cov of the same | 31 |
that can be used | 31 |
cleavage site absent in | 31 |
the fact that the | 31 |
the time of writing | 31 |
may be associated with | 31 |
phase i clinical trial | 31 |
vitro antiviral activity and | 31 |
the s and s | 31 |
antiviral activity and projection | 31 |
and the number of | 31 |
has not yet been | 31 |
domain of the spike | 31 |
from sars to mers | 31 |
infection prevention and control | 31 |
dosing design of hydroxychloroquine | 31 |
viral load in the | 30 |
of the host cell | 30 |
of the virus is | 30 |
posterior oropharyngeal saliva samples | 30 |
hip and knee arthroplasty | 30 |
load in posterior oropharyngeal | 30 |
the structure of the | 30 |
structure of sars coronavirus | 30 |
is yet to be | 30 |
airway epithelial cells and | 30 |
study group of the | 30 |
a less toxic derivative | 30 |
manifestations of hospitalized patients | 30 |
as a possible cause | 30 |
a possible cause of | 30 |
less toxic derivative of | 30 |
allergy and infectious diseases | 30 |
were found to have | 30 |
and serum antibody responses | 30 |
institute of allergy and | 30 |
group of the international | 30 |
is closely related to | 30 |
the virus to the | 30 |
the potential risk of | 30 |
the start of the | 30 |
to be involved in | 30 |
and other lineage b | 30 |
other lineage b betacoronaviruses | 30 |
ncov contains a furin | 30 |
of sars and mers | 30 |
have been used to | 30 |
the human ace receptor | 30 |
toxic derivative of chloroquine | 30 |
like cleavage site absent | 30 |
of their replication and | 30 |
the basic reproduction number | 30 |
the transmission of the | 30 |
an update on the | 30 |
by a sars coronavirus | 30 |
are involved in the | 30 |
a potential target for | 30 |
in posterior oropharyngeal saliva | 30 |
read and approved the | 30 |
a basis for design | 30 |
protease provides a basis | 30 |
be due to the | 30 |
main protease provides a | 30 |
the diagnosis and treatment | 30 |
receptor usage for sars | 30 |
in the lower respiratory | 30 |
the activation of the | 30 |
to prevent the spread | 30 |
porcine epidemic diarrhea virus | 30 |
viral load in posterior | 30 |
national institute of allergy | 30 |
by the fact that | 30 |
in the s subunit | 30 |
to acute respiratory distress | 30 |
for design of improved | 30 |
was used as a | 30 |
the viral spike protein | 30 |
the first cases of | 30 |
in the middle east | 30 |
in the form of | 30 |
for patients with severe | 30 |
plays a key role | 30 |
distributed under the terms | 30 |
parts of the world | 30 |
the onset of the | 30 |
receptor binding domain of | 29 |
and shortness of breath | 29 |
in dromedary camels in | 29 |
t cell responses to | 29 |
p t e d | 29 |
carrier transmission of covid | 29 |
the presence or absence | 29 |
high expression of ace | 29 |
the antiviral effects of | 29 |
their replication and pathogenesis | 29 |
responses during infection by | 29 |
reverse transcription polymerase chain | 29 |
declare no competing interests | 29 |
the number of infected | 29 |
t e d m | 29 |
has been observed in | 29 |
clinical progression and viral | 29 |
it is difficult to | 29 |
at a concentration of | 29 |
antiviral activity against sars | 29 |
an overview of their | 29 |
the presence of viral | 29 |
the gene source of | 29 |
as part of the | 29 |
coronavirus as a possible | 29 |
the rbd of the | 29 |
d m a n | 29 |
the duration of the | 29 |
as the gene source | 29 |
overview of their replication | 29 |
samples and serum antibody | 29 |
crucial role of angiotensin | 29 |
at the level of | 29 |
possible cause of severe | 29 |
is effective in inhibiting | 29 |
presumed asymptomatic carrier transmission | 29 |
respiratory syndrome coronavirus as | 29 |
effective in inhibiting sars | 29 |
mechanisms of action of | 29 |
the viral life cycle | 29 |
c e p t | 29 |
asymptomatic carrier transmission of | 29 |
to be the most | 29 |
these data indicate that | 29 |
a crucial role of | 29 |
in the production of | 29 |
and viral load in | 29 |
progression and viral load | 29 |
can be used as | 29 |
c c e p | 29 |
role of angiotensin converting | 29 |
a c c e | 29 |
the novel coronavirus disease | 29 |
for patients with covid | 29 |
e d m a | 29 |
oropharyngeal saliva samples and | 29 |
from patients with covid | 29 |
compassionate use of remdesivir | 29 |
authors declare no competing | 29 |
saliva samples and serum | 29 |
of sars coronavirus infection | 29 |
antibody responses during infection | 29 |
during infection by sars | 29 |
are summarized in table | 29 |
the host immune response | 29 |
on the origin and | 29 |
in the general population | 29 |
a randomized controlled trial | 29 |
incubated for h at | 29 |
is a potent inhibitor | 29 |
serum antibody responses during | 29 |
e p t e | 29 |
are shown in table | 29 |
was performed using the | 28 |
study was approved by | 28 |
severe acute respiratory infection | 28 |
immune response in patients | 28 |
no reuse allowed without | 28 |
detection of viral rna | 28 |
temporal profiles of viral | 28 |
the severity of covid | 28 |
from animals to humans | 28 |
a major role in | 28 |
the recognition of sars | 28 |
therapy in severe covid | 28 |
in the early stages | 28 |
reuse allowed without permission | 28 |
tested negative for sars | 28 |
early stage of the | 28 |
in a community outbreak | 28 |
that the use of | 28 |
domain complexed with receptor | 28 |
our understanding of the | 28 |
mice transgenic for human | 28 |
that there is a | 28 |
profiles of viral load | 28 |
t cell responses in | 28 |
coronaviruses as the gene | 28 |
with the host cell | 28 |
of its spike protein | 28 |
the upper and lower | 28 |
the interaction of the | 28 |
the risk of infection | 28 |
article distributed under the | 28 |
early stages of the | 28 |
i and type iii | 28 |
characteristics and outcomes of | 28 |
in the p position | 28 |
the safety and efficacy | 28 |
access article distributed under | 28 |
severe cases of covid | 28 |
as compared to the | 28 |
were included in the | 28 |
may contribute to the | 28 |
analysis of the sars | 28 |
oral transmission of sars | 28 |
characteristics of novel coronavirus | 27 |
implication of multiple shedding | 27 |
to reduce the risk | 27 |
sars and mers coronaviruses | 27 |
a wide variety of | 27 |
clinical characteristics of patients | 27 |
mediated by the viral | 27 |
during the incubation period | 27 |
we found that the | 27 |
the number of cases | 27 |
the detection of viral | 27 |
a public health emergency | 27 |
it remains to be | 27 |
severity of the disease | 27 |
these findings suggest that | 27 |
can be used for | 27 |
respiratory syndrome coronavirus vaccine | 27 |
has also been reported | 27 |
the basis of the | 27 |
with respect to the | 27 |
these data suggest that | 27 |
by the end of | 27 |
and serological investigation of | 27 |
a community outbreak of | 27 |
the novel coronavirus sars | 27 |
in response to sars | 27 |
divergence of the novel | 27 |
the potential role of | 27 |
have the potential to | 27 |
than that of sars | 27 |
the outbreak of covid | 27 |
the absence of any | 27 |
pregnant women with covid | 27 |
the entry of the | 27 |
case of middle east | 27 |
the human respiratory tract | 27 |
domesticated animals to sars | 27 |
influenza a h n | 27 |
the origin of the | 27 |
genome composition and divergence | 27 |
the interaction between the | 27 |
the mechanism of action | 27 |
plasma therapy in severe | 27 |
from sars and mers | 27 |
was added to the | 27 |
clinical features of covid | 27 |
and divergence of the | 27 |
molecular and serological investigation | 27 |
expression profiling of ace | 27 |
one of the major | 27 |
feline infectious peritonitis virus | 27 |
of multiple shedding routes | 27 |
has been identified as | 27 |
load in a community | 27 |
it is possible to | 27 |
novel severe acute respiratory | 27 |
sars coronavirus spike receptor | 27 |
and personal protective equipment | 27 |
death in patients with | 27 |
may be related to | 27 |
the ongoing wuhan outbreak | 26 |
neuroinvasive potential of sars | 26 |
vertical transmission of sars | 26 |
national health commission of | 26 |
are known to be | 26 |
innate immune response to | 26 |
health emergency of international | 26 |
the innate immune system | 26 |
of patients with coronavirus | 26 |
in treatment of covid | 26 |
for the diagnosis and | 26 |
ongoing wuhan outbreak and | 26 |
is thought to be | 26 |
protein for risk of | 26 |
in view of the | 26 |
in contrast to the | 26 |
and lower respiratory tract | 26 |
all authors contributed to | 26 |
be involved in the | 26 |
bats are natural reservoirs | 26 |
novel coronavirus from the | 26 |
in the near future | 26 |
severe acute respiratory infections | 26 |
are included in the | 26 |
were more likely to | 26 |
its spike protein for | 26 |
the new york city | 26 |
the limit of detection | 26 |
management of severe acute | 26 |
have been found to | 26 |
in vitro activity against | 26 |
evidence for gastrointestinal infection | 26 |
gastrointestinal infection of sars | 26 |
from the ongoing wuhan | 26 |
in the range of | 26 |
natural reservoirs of sars | 26 |
transmission of severe acute | 26 |
risk of human transmission | 26 |
for risk of human | 26 |
the humoral immune response | 26 |
china clinical characteristics of | 26 |
in line with the | 26 |
as shown in fig | 26 |
for gastrointestinal infection of | 26 |
in patients with cancer | 26 |
with suspected or confirmed | 26 |
spike protein for risk | 26 |
hydroxychloroquine in patients with | 26 |
the united arab emirates | 26 |
it was reported that | 26 |
patients hospitalized with covid | 26 |
a retrospective review of | 26 |
potential conflict of interest | 26 |
the most common symptoms | 26 |
public health emergency of | 26 |
alone or in combination | 26 |
stage of the disease | 26 |
coronavirus from the ongoing | 26 |
in the formation of | 26 |
been found to be | 26 |
neurologic manifestations of hospitalized | 26 |
emergency of international concern | 26 |
intermediate hosts of sars | 26 |
to the severity of | 26 |
has been found to | 26 |
in the regulation of | 26 |
on the epithelial cells | 25 |
the spike protein and | 25 |
into the host cells | 25 |
and cd t cell | 25 |
in combination with other | 25 |
and other respiratory viruses | 25 |
that the majority of | 25 |
update on the status | 25 |
the viral load in | 25 |
which is consistent with | 25 |
a vital role in | 25 |
cytokines and chemokines in | 25 |
outbreak and modeling of | 25 |
clinical management of severe | 25 |
s subunit of the | 25 |
and functional basis of | 25 |
coronavirus in dromedary camels | 25 |
ritonavir in the treatment | 25 |
be one of the | 25 |
retrospective review of medical | 25 |
structural and functional basis | 25 |
and modeling of its | 25 |
wuhan outbreak and modeling | 25 |
in humans with covid | 25 |
human monoclonal antibody blocking | 25 |
due to the presence | 25 |
lower respiratory tract infection | 25 |
diamond princess cruise ship | 25 |
have been detected in | 25 |
potential evidence for persistent | 25 |
as shown in table | 25 |
an ic value of | 25 |
new insights into the | 25 |
may be involved in | 25 |
and adaptive immune responses | 25 |
review of medical records | 25 |
used in the treatment | 25 |
a severe acute respiratory | 25 |
approved the final manuscript | 25 |
have shown that the | 25 |
entry by using human | 25 |
authors would like to | 25 |
persistent fecal viral shedding | 25 |
vertical transmission potential of | 25 |
for persistent fecal viral | 25 |
intrauterine vertical transmission potential | 25 |
and the cardiovascular system | 25 |
studies have demonstrated that | 25 |
the rbd of sars | 25 |
replication in cell culture | 25 |
modeling of its spike | 25 |
for critically ill patients | 25 |
and the risk of | 25 |
have been observed in | 25 |
in chinese horseshoe bats | 25 |
for the design of | 25 |
infection and potential evidence | 25 |
are natural reservoirs of | 25 |
functional basis of sars | 25 |
an urgent need for | 25 |
vaccine and therapeutic development | 25 |
evidence for persistent fecal | 25 |
the disease caused by | 25 |
of mouse hepatitis virus | 25 |
the use of a | 25 |
to be able to | 25 |
risk factors associated with | 25 |
to be effective against | 25 |
and potential evidence for | 25 |
and the possibility of | 25 |
neonates born to mothers | 25 |
and immunogenicity of a | 25 |
sars coronavirus spike protein | 25 |
it has been suggested | 25 |
monoclonal antibody blocking sars | 25 |
the expression of the | 25 |
characteristics of pediatric sars | 25 |
cell responses to sars | 25 |
in the lungs and | 25 |
in patients of novel | 24 |
could be used to | 24 |
syndrome associated with sars | 24 |
clinical characteristics of covid | 24 |
and discovery of its | 24 |
since the beginning of | 24 |
expression of ace receptor | 24 |
sars coronavirus infection and | 24 |
evolution of coronavirus spike | 24 |
coronaviruses in malayan pangolins | 24 |
well as in the | 24 |
have been identified in | 24 |
with coronavirus disease in | 24 |
it is known that | 24 |
for vaccine and therapeutic | 24 |
in the serum of | 24 |
immune responses to sars | 24 |
use of remdesivir for | 24 |
remarks at the media | 24 |
and its implications for | 24 |
the national institute of | 24 |
viral shedding and transmissibility | 24 |
the national institutes of | 24 |
airborne transmission of sars | 24 |
to that of the | 24 |
have also been reported | 24 |
grade soluble human ace | 24 |
for detection of sars | 24 |
community outbreak of coronavirus | 24 |
are likely to be | 24 |
infections in engineered human | 24 |
the vast majority of | 24 |
a broad range of | 24 |
temporal dynamics in viral | 24 |
of human immunodeficiency virus | 24 |
dynamics in viral shedding | 24 |
was reported to be | 24 |
therapeutic options for the | 24 |
therapies on coronavirus disease | 24 |
detection of the virus | 24 |
vero e cells were | 24 |
was obtained from the | 24 |
and clinical therapies on | 24 |
by using human ace | 24 |
epithelial cells of the | 24 |
therapeutic targets for sars | 24 |
in engineered human tissues | 24 |
at the media briefing | 24 |
igg antibody to sars | 24 |
had a history of | 24 |
more likely to be | 24 |
and transmissibility of covid | 24 |
remains to be determined | 24 |
respiratory syndrome coronavirus receptor | 24 |
lopinavir ritonavir in the | 24 |
the media briefing on | 24 |
no conflicts of interest | 24 |
in acute respiratory distress | 24 |
were infected with sars | 24 |
the s domain of | 24 |
play a key role | 24 |
related coronaviruses in malayan | 24 |
clinical therapies on coronavirus | 24 |
shedding and transmissibility of | 24 |
target for vaccine and | 24 |
a broad spectrum of | 24 |
viral entry into the | 24 |
used for the treatment | 24 |
patients of novel coronavirus | 24 |
transmission potential of covid | 24 |
engineered human tissues using | 24 |
in the olfactory epithelium | 24 |
transmission and clinical therapies | 24 |
it has also been | 24 |
for the prevention of | 24 |
to the active site | 24 |
and the pathogenesis of | 24 |
respiratory syndrome coronavirus a | 24 |
different parts of the | 24 |
active site of sars | 24 |
structures of the sars | 24 |
the pathogenicity of sars | 24 |
and evolution of coronavirus | 24 |
the results showed that | 24 |
in the new york | 24 |
to the use of | 24 |
the epidemiological characteristics of | 23 |
an outbreak of pneumonia | 23 |
efficacy in treatment of | 23 |
publicly reported confirmed cases | 23 |
epidemiology and pathogenesis of | 23 |
and intrauterine vertical transmission | 23 |
patients admitted to hospital | 23 |
discovery of its inhibitors | 23 |
of remdesivir for patients | 23 |
inhibitors of the sars | 23 |
and evolution of the | 23 |
of chloroquine and hydroxychloroquine | 23 |
distress syndrome and death | 23 |
dysregulation of immune response | 23 |
both epidemic and zoonotic | 23 |
novel coronavirus outbreak of | 23 |
in the fight against | 23 |
the first week of | 23 |
in the sera of | 23 |
further studies are required | 23 |
the course of infection | 23 |
epidemic and zoonotic coronaviruses | 23 |
a mouse model of | 23 |
infection in nine pregnant | 23 |
a target for vaccine | 23 |
by the addition of | 23 |
days after onset of | 23 |
between the two groups | 23 |
disease and unexposed individuals | 23 |
uses the ace receptor | 23 |
will need to be | 23 |
entry into the cell | 23 |
there was no significant | 23 |
incubation period of coronavirus | 23 |
development of vaccines and | 23 |
apparent efficacy in treatment | 23 |
was not detected in | 23 |
similar to those of | 23 |
chloroquine phosphate has shown | 23 |
remdesivir for patients with | 23 |
vaccine targets for the | 23 |
it is essential to | 23 |
in the field of | 23 |
of personal protective equipment | 23 |
treatment of coronavirus disease | 23 |
in a variety of | 23 |
in the cerebrospinal fluid | 23 |
the sensitivity of the | 23 |
the fusion of the | 23 |
have a role in | 23 |
pathogenesis of coronavirus disease | 23 |
in viral shedding and | 23 |
of hydroxychloroquine and azithromycin | 23 |
an intensive care unit | 23 |
the early phase of | 23 |
of lopinavir ritonavir in | 23 |
there is currently no | 23 |
coronavirus in humans with | 23 |
clinical characteristics and intrauterine | 23 |
period of coronavirus disease | 23 |
the protein data bank | 23 |
the control of the | 23 |
has yet to be | 23 |
the authors would like | 23 |
human tissues using clinical | 23 |
both in vitro and | 23 |
characteristics and intrauterine vertical | 23 |
for each of the | 23 |
was not associated with | 23 |
the molecular biology of | 23 |
cells infected with sars | 23 |
of immune response in | 23 |
review of the literature | 23 |
not included in the | 23 |
was found to have | 23 |
presence of the virus | 23 |
the coronavirus study group | 23 |
of potential vaccine targets | 23 |
potent inhibitor of sars | 23 |
discovery of potential drugs | 23 |
a high level of | 23 |
in nine pregnant women | 23 |
and the development of | 23 |
the diamond princess cruise | 23 |
and the use of | 23 |
is associated with a | 23 |
inhibits both epidemic and | 23 |
in the diagnosis of | 22 |
than that of the | 22 |
for the identification of | 22 |
the immune system and | 22 |
genomic characterization of a | 22 |
targets for the covid | 22 |
and pathogenesis of coronavirus | 22 |
coronavirus outbreak of global | 22 |
in mice transgenic for | 22 |
correlation of chest ct | 22 |
pangolin origin of sars | 22 |
were detected in the | 22 |
for the use of | 22 |
systematic review of the | 22 |
epitopes of the sars | 22 |
shown apparent efficacy in | 22 |
coronaviridae study group of | 22 |
has shown apparent efficacy | 22 |
which is responsible for | 22 |
of this study was | 22 |
stages of the disease | 22 |
the epidemic and the | 22 |
potential vaccine targets for | 22 |
min at room temperature | 22 |
distribution of severe acute | 22 |
and treatment of sars | 22 |
encephalitis associated with sars | 22 |
accepted article this article | 22 |
rna was extracted from | 22 |
respiratory syndrome coronavirus by | 22 |
time to clinical improvement | 22 |
chest ct and rt | 22 |
at the university of | 22 |
the s protein in | 22 |
antibody to sars cov | 22 |
analysis was performed using | 22 |
the pathogenesis of severe | 22 |
article this article is | 22 |
antibodies in dromedary camels | 22 |
to the spike protein | 22 |
outbreak of global health | 22 |
at room temperature for | 22 |
a novel coronavirus outbreak | 22 |
binding domain of sars | 22 |
of a bat sars | 22 |
at higher risk of | 22 |
of sars cov m | 22 |
during the acute phase | 22 |
the host immune system | 22 |
of pregnant women with | 22 |
a significant increase in | 22 |
is due to the | 22 |
of global health concern | 22 |
in most of the | 22 |
viral rna in the | 22 |
and incubated for h | 22 |
is no evidence that | 22 |
the case of covid | 22 |
acute respiratory syndrome and | 22 |
the sequence of the | 22 |
treatment with convalescent plasma | 22 |
the treatment of novel | 22 |
the development of sars | 22 |
samples from patients with | 22 |
one of the first | 22 |
prolonged presence of sars | 22 |
a small number of | 22 |
coronavirus fusion inhibitor targeting | 22 |
in any of the | 22 |
and clinical features of | 22 |
and outcomes of patients | 22 |
from publicly reported confirmed | 22 |
will be required to | 22 |
and clinical course of | 22 |
s s cleavage site | 22 |
are yet to be | 22 |
it is believed that | 22 |
pneumonia in clinical studies | 22 |
outside the submitted work | 22 |
to mothers with covid | 22 |
the enzymatic activity of | 22 |
analysis of the novel | 22 |
endothelial cell infection and | 22 |
sars coronavirus nucleocapsid protein | 22 |
the context of covid | 22 |
phosphate has shown apparent | 22 |
the virus can be | 22 |
at the plasma membrane | 22 |
the impact of the | 22 |
associated pneumonia in clinical | 22 |
the evolution of the | 22 |
of ace receptor of | 22 |
cells were infected with | 22 |
transcriptase polymerase chain reaction | 22 |
targets of t cell | 22 |
has been suggested that | 22 |
fusion of the viral | 22 |
of antibodies against sars | 22 |
on the day of | 22 |
approved for the treatment | 22 |
coronavirus replication in cell | 22 |
the nucleocapsid protein of | 22 |
induced acute lung injury | 22 |
the epidemiology and pathogenesis | 22 |
of chest ct and | 22 |
can also be used | 22 |
closely related to sars | 21 |
acute respiratory syndrome the | 21 |
rna dependent rna polymerase | 21 |
further studies are needed | 21 |
role of lopinavir ritonavir | 21 |
assay for the detection | 21 |
in the active site | 21 |
virological and clinical findings | 21 |
humoral response to diagnose | 21 |
and in vivo studies | 21 |
before the onset of | 21 |
in the prevention and | 21 |
and its impact on | 21 |
the cells were washed | 21 |
that uses the ace | 21 |
is similar to that | 21 |
of vero e cells | 21 |
in this study were | 21 |
inhibitor of sars coronavirus | 21 |
sars coronavirus infection in | 21 |
therapeutic efficacy of remdesivir | 21 |
treatment with lopinavir ritonavir | 21 |
during the outbreak of | 21 |
of the spike glycoprotein | 21 |
epithelial cells of oral | 21 |
cells were washed with | 21 |
as potential treatment for | 21 |
be effective against sars | 21 |
baricitinib as potential treatment | 21 |
signs and symptoms of | 21 |
diagnose novel coronavirus disease | 21 |
that the virus can | 21 |
nucleocapsid protein of sars | 21 |
proteins of severe acute | 21 |
early humoral response to | 21 |
identification of potential vaccine | 21 |
a result of the | 21 |
cells of oral mucosa | 21 |
the formation of a | 21 |
as soon as possible | 21 |
for min at room | 21 |
genome sequence of sars | 21 |
of the respiratory tract | 21 |
a descriptive study clinical | 21 |
cleavage site in the | 21 |
at increased risk for | 21 |
this is an open | 21 |
the s proteins of | 21 |
the human immune system | 21 |
the absence of a | 21 |
first case of meningitis | 21 |
characterization of a bat | 21 |
efficacy of remdesivir and | 21 |
added to each well | 21 |
with convalescent plasma for | 21 |
meningitis encephalitis associated with | 21 |
acute respiratory syndrome virus | 21 |
clinical trials have been | 21 |
during the sars outbreak | 21 |
remdesivir and combination lopinavir | 21 |
and interferon beta against | 21 |
antibody test for sars | 21 |
coronavirus that uses the | 21 |
of remdesivir and combination | 21 |
comparative therapeutic efficacy of | 21 |
droplet and contact precautions | 21 |
o o f the | 21 |
the use of convalescent | 21 |
time polymerase chain reaction | 21 |
the virus into the | 21 |
human transmission of sars | 21 |
the development of the | 21 |
for up to days | 21 |
ivermectin inhibits the replication | 21 |
virus in chinese horseshoe | 21 |
the treatment of the | 21 |
combined antibody test for | 21 |
and discovery of potential | 21 |
to evaluate the safety | 21 |
were negative for sars | 21 |
epidemic and the challenges | 21 |
antiviral effects of chloroquine | 21 |
study clinical characteristics of | 21 |
ncov acute respiratory disease | 21 |
authors read and approved | 21 |
in the early phase | 21 |
profiling early humoral response | 21 |
interferon beta against mers | 21 |
in suspected human cases | 21 |
a significant role in | 21 |
by human monoclonal antibodies | 21 |
admitted to the icu | 21 |
samples were collected from | 21 |
the primary cause of | 21 |
converting enzyme protects from | 21 |
infection in the united | 21 |
a pandemic on march | 21 |
syndrome coronavirus in the | 21 |
of the fusion core | 21 |
cov cl pro cleavage | 21 |
infectious diseases society of | 21 |
during the study period | 21 |
response to diagnose novel | 21 |
patients with confirmed covid | 21 |
patients with severe disease | 21 |
included in the study | 21 |
viral replication in the | 21 |
is essential for the | 21 |
preliminary identification of potential | 21 |
to evaluate the efficacy | 21 |
van doremalen et al | 21 |
from severe acute respiratory | 21 |
patients with acute respiratory | 21 |
of patients admitted to | 21 |
in the intensive care | 21 |
initial virological and clinical | 21 |
of t cells in | 21 |
lower than that of | 21 |
drug ivermectin inhibits the | 20 |
d g mutation in | 20 |
in the design of | 20 |
with an ic value | 20 |
to diagnose novel coronavirus | 20 |
of type i ifn | 20 |
of the innate immune | 20 |
of novel coronavirus infection | 20 |
cell epitopes of the | 20 |
viral loads in the | 20 |
chloroquine is a potent | 20 |
associated with the covid | 20 |
angiotensin i to angiotensin | 20 |
had no role in | 20 |
analysis of therapeutic targets | 20 |
testing in coronavirus disease | 20 |
pneumonia in rhesus macaques | 20 |
application of a rapid | 20 |
the viral s protein | 20 |
be infected with sars | 20 |
incidence of thrombotic complications | 20 |
like virus in chinese | 20 |
from a symptomatic patient | 20 |
of potential drugs by | 20 |
of therapeutic targets for | 20 |
phase iii clinical trial | 20 |
the one health concept | 20 |
of pneumonia of unknown | 20 |
rna in faecal samples | 20 |
igg combined antibody test | 20 |
as a positive control | 20 |
the urgent need for | 20 |
associated with poor prognosis | 20 |
acute lung injury in | 20 |
coronavirus infection and spread | 20 |
personal protective equipment contamination | 20 |
sequence of the sars | 20 |
humoral and cellular immune | 20 |
the main protease of | 20 |
and the role of | 20 |
of this study is | 20 |
caused by the novel | 20 |
mice infected with sars | 20 |
cd t cell responses | 20 |
identification and characterization of | 20 |
replication of the virus | 20 |
key role in the | 20 |
genome sequence of the | 20 |
human immunodeficiency virus type | 20 |
highly expressed in nasal | 20 |
has been found in | 20 |
by the immune system | 20 |
with ic values of | 20 |
a recombinant adenovirus type | 20 |
protective equipment contamination by | 20 |
receptor ace is an | 20 |
of ace in the | 20 |
a skilled nursing facility | 20 |
an overview of the | 20 |
confirmed cases of covid | 20 |
the nsp and nsp | 20 |
this study was to | 20 |
equipment contamination by severe | 20 |
in the city of | 20 |
h at room temperature | 20 |
revealed the presence of | 20 |
was observed in the | 20 |
the virus has been | 20 |
clinical course of patients | 20 |
of the receptor binding | 20 |
in nasal epithelial cells | 20 |
were observed in the | 20 |
opening remarks at the | 20 |
case of meningitis encephalitis | 20 |
ncov on the epithelial | 20 |
be explained by the | 20 |
in the receptor binding | 20 |
viral rna in faecal | 20 |
in specific cell subsets | 20 |
epithelial cells and is | 20 |
pcr testing in coronavirus | 20 |
like coronavirus that uses | 20 |
antibody response to sars | 20 |
of amino acid residues | 20 |
and potential therapeutic target | 20 |
and clinical application of | 20 |
respiratory syndrome coronavirus papain | 20 |
potential drugs by computational | 20 |
combination of hydroxychloroquine and | 20 |
is involved in the | 20 |
of meningitis encephalitis associated | 20 |
on the efficacy and | 20 |
human bronchial epithelial cells | 20 |
increase in the number | 20 |
cd t cells in | 20 |
gene in human airway | 20 |
cell subsets across tissues | 20 |
that most of the | 20 |
was identified as the | 20 |
little is known about | 20 |
of j o u | 20 |
was associated with a | 20 |
onset of symptoms to | 20 |
the binding of sars | 20 |
a high degree of | 20 |
infection of human lung | 20 |
drugs by computational methods | 20 |
clinical application of a | 20 |
disease in china a | 20 |
is associated with the | 20 |
of a rapid igm | 20 |
a total of patients | 20 |
and disease severity in | 20 |
cov and middle east | 20 |
and is detected in | 20 |
contamination by severe acute | 20 |
the use of the | 20 |
in the peripheral blood | 20 |
a potential inhibitor of | 20 |
authors contributed to the | 20 |
to the s protein | 20 |
specific cell subsets across | 20 |
the lancet infectious diseases | 20 |
ace is an interferon | 20 |
that there is no | 20 |
as a consequence of | 20 |
of the viral envelope | 20 |
development and clinical application | 20 |
probable bat origin a | 20 |
the s subunit is | 20 |
is associated with decreased | 20 |
complete genome sequence of | 20 |
of the current pandemic | 19 |
are highly expressed in | 19 |
of convalescent plasma for | 19 |
should be given to | 19 |
the respiratory failure of | 19 |
at a higher risk | 19 |
of a series of | 19 |
is supported by the | 19 |
hydroxychloroquine and azithromycin in | 19 |
the identification of the | 19 |
serum antibodies in dromedary | 19 |
respiratory failure of covid | 19 |
and endotheliitis in covid | 19 |
spread of the disease | 19 |
in patients with novel | 19 |
under a author funder | 19 |
for at least days | 19 |
rna expression profiling of | 19 |
research is needed to | 19 |
in a number of | 19 |
in the current study | 19 |
with the development of | 19 |
pneumonia of unknown etiology | 19 |
a case series of | 19 |
clinical and immunological features | 19 |
expression of ace in | 19 |
the importance of the | 19 |
s and s pn | 19 |
the host cell receptor | 19 |
in adults with severe | 19 |
of coronaviruses on inanimate | 19 |
we did not observe | 19 |
this version posted june | 19 |
stimulated gene in human | 19 |
be associated with a | 19 |
probable pangolin origin of | 19 |
a link to the | 19 |
as a negative control | 19 |
these results indicate that | 19 |
of a recombinant adenovirus | 19 |
all authors read and | 19 |
health commission of the | 19 |
a comparative serological study | 19 |
coronaviruses on inanimate surfaces | 19 |
and vaccines for covid | 19 |
of the patients with | 19 |
in the olfactory bulb | 19 |
acute respiratory infection when | 19 |
as a function of | 19 |
to note that the | 19 |
on the cell surface | 19 |
olfactory and gustatory dysfunctions | 19 |
in hace transgenic mice | 19 |
found to be the | 19 |
of sars coronavirus in | 19 |
nonhuman primate model of | 19 |
the newly identified coronavirus | 19 |
it is not clear | 19 |
outbreak of middle east | 19 |
and acute respiratory distress | 19 |
fatal severe acute respiratory | 19 |
immunopathology on challenge with | 19 |
and tumor necrosis factor | 19 |
patients with suspected sars | 19 |
of an inactivated vaccine | 19 |
molecular evolutionary genetics analysis | 19 |
primate model of common | 19 |
in the host cell | 19 |
outcomes in patients with | 19 |
a high prevalence of | 19 |
host cell entry of | 19 |
and reproduction in any | 19 |
by binding to the | 19 |
mers coronavirus in dromedary | 19 |
could be due to | 19 |
cell infection and endotheliitis | 19 |
cells and is detected | 19 |
view a copy of | 19 |
risk of developing severe | 19 |
have no conflict of | 19 |
the first wave of | 19 |
with poor prognosis in | 19 |
respiratory syndrome coronavirus entry | 19 |
it is noteworthy that | 19 |
be found in the | 19 |
are similar to those | 19 |
is known to be | 19 |
to view a copy | 19 |
at increased risk of | 19 |
rapid transmission of sars | 19 |
as well as its | 19 |
be detected in the | 19 |
of influenza a virus | 19 |
mechanisms and potential therapeutic | 19 |
a limited number of | 19 |
the city of wuhan | 19 |
cannot be ruled out | 19 |
version of the manuscript | 19 |
in the central nervous | 19 |
the coronavirus spike protein | 19 |
reproduction in any medium | 19 |
infection and endotheliitis in | 19 |
with that of sars | 19 |
detected in specific cell | 19 |
the presence of antibodies | 19 |
options for the novel | 19 |
is detected in specific | 19 |
for diagnosis of covid | 19 |
this version posted august | 19 |
in light of the | 19 |
available under a author | 19 |
in this article are | 19 |
was found that the | 19 |
s domain of the | 19 |
will be important to | 19 |
been used to treat | 19 |
viral rna was detected | 19 |
icu patients with covid | 19 |
the outbreak of the | 19 |
media briefing on covid | 19 |
a copy of this | 19 |
cases have been reported | 19 |
respiratory syndrome coronavirus the | 19 |
management of patients with | 19 |
are at higher risk | 19 |
and moderate coronavirus disease | 19 |
are associated with poor | 19 |
the binding site of | 19 |
modified vaccinia virus ankara | 19 |
a multiplicity of infection | 19 |
of traditional chinese medicine | 19 |
for h at room | 19 |
severe acute lung failure | 19 |
molecular mechanisms and potential | 19 |
coronavirus middle east respiratory | 19 |
were obtained from the | 19 |
been shown to inhibit | 19 |
severe and moderate coronavirus | 19 |
as a model for | 19 |
in the transmission of | 19 |
neutralising serum antibodies in | 18 |
to prevent and treat | 18 |
improves outcome of mers | 18 |
on the s protein | 18 |
influenza a virus in | 18 |
closely related to the | 18 |
immune response to the | 18 |
by novel coronavirus from | 18 |
a systematic review on | 18 |
been shown to have | 18 |
inactivation with biocidal agents | 18 |
the emergence of the | 18 |
plays a critical role | 18 |
s protein is the | 18 |
on replication and pathogenesis | 18 |
have been used for | 18 |
was performed using a | 18 |
has been used to | 18 |
in the process of | 18 |
the binding affinity of | 18 |
number of confirmed cases | 18 |
receptor recognition by novel | 18 |
short period of time | 18 |
on inanimate surfaces and | 18 |
it is worth noting | 18 |
patients with lung cancer | 18 |
update on replication and | 18 |
with the ace receptor | 18 |
is worth noting that | 18 |
development of a vaccine | 18 |
during the first week | 18 |
molecular biology of coronaviruses | 18 |
novel coronavirus infection in | 18 |
caused by the severe | 18 |
is supported by a | 18 |
in fecal samples from | 18 |
and rapid transmission of | 18 |
a safe and effective | 18 |
cov pl pro was | 18 |
due to the high | 18 |
inactivated severe acute respiratory | 18 |
protects from severe acute | 18 |
randomized to ravulizumab bsc | 18 |
a small animal model | 18 |
model of common marmoset | 18 |
and taste disorders in | 18 |
syndrome coronavirus neutralising serum | 18 |
coronavirus disease in wuhan | 18 |
of the coronavirus study | 18 |
should be considered as | 18 |
aged years or older | 18 |
infection in dromedary camels | 18 |
on the host cell | 18 |
of the first cases | 18 |
the understanding of the | 18 |
with an ic of | 18 |
there are currently no | 18 |
recognition by novel coronavirus | 18 |
patients admitted to the | 18 |
from severe acute lung | 18 |
the clinical course of | 18 |
of an outbreak of | 18 |
the outbreak of novel | 18 |
the course of covid | 18 |
and death in patients | 18 |
expression of the sars | 18 |
herpes simplex virus type | 18 |
an increase in the | 18 |
a median of days | 18 |
characteristics of patients infected | 18 |
suspected or confirmed covid | 18 |
of a new human | 18 |
of the newly identified | 18 |
of igg and igm | 18 |
phase of the disease | 18 |
which may lead to | 18 |
persistence of coronaviruses on | 18 |
structure of mpro from | 18 |
the nature of the | 18 |
neuronal death in the | 18 |
enzyme protects from severe | 18 |
presence of viral rna | 18 |
of the viral spike | 18 |
and protective immunity in | 18 |
infection and rapid transmission | 18 |
a fatal case of | 18 |
cell rna expression profiling | 18 |
spike protein is a | 18 |
ribavirin in the treatment | 18 |
be more susceptible to | 18 |
control the spread of | 18 |
who tested positive for | 18 |
duration of viral shedding | 18 |
exposure to the virus | 18 |
genome sequences of sars | 18 |
and is responsible for | 18 |
disease severity in patients | 18 |
coronavirus neutralising serum antibodies | 18 |
cases of severe acute | 18 |
potential intermediate hosts of | 18 |
cases of middle east | 18 |
this version posted april | 18 |
drugs for treatment of | 18 |
expression reveals the potential | 18 |
data analysis on the | 18 |
state of the art | 18 |
respiratory syndrome coronavirus neutralising | 18 |
testing positive for sars | 18 |
discovery of a novel | 18 |
activation of the severe | 18 |
admitted to hospital with | 18 |
of human coronavirus oc | 18 |
there is no specific | 18 |
in a skilled nursing | 18 |
tears and conjunctival secretions | 18 |
respiratory syndrome in the | 18 |
respiratory tract infection in | 18 |
of the disease and | 18 |
syndrome and death in | 18 |
to the huanan seafood | 18 |
rapid spread of sars | 18 |
a mortality rate of | 18 |
university of hong kong | 18 |
neutralization of sars coronavirus | 18 |
for sars and mers | 18 |
we were able to | 18 |
adults with severe covid | 18 |
were retrieved from the | 18 |
in the past years | 18 |
in patients with mild | 18 |
a first case of | 18 |
for design of anti | 18 |
it is crucial to | 18 |
has been proposed as | 18 |
factors associated with acute | 18 |
is caused by a | 18 |
cells were treated with | 18 |
in humans and animals | 18 |
associated with disease severity | 18 |
amino acid sequence identity | 18 |
the republic of korea | 18 |
after onset of symptoms | 18 |
are considered to be | 18 |
nasopharyngeal and oropharyngeal swabs | 18 |
the majority of patients | 18 |
ace expression reveals the | 18 |
characterization of severe acute | 18 |
can be used in | 18 |
for the control of | 18 |
did not show any | 18 |
drives development of covid | 17 |
the genome of sars | 17 |
patients recovered from covid | 17 |
igg antibodies against sars | 17 |
approved by the institutional | 17 |
rbd of the s | 17 |
binding to the ace | 17 |
permitted by statutory regulation | 17 |
reported the presence of | 17 |
lopinavir ritonavir or interferon | 17 |
the huanan seafood market | 17 |
target of neutralizing antibodies | 17 |
for the evaluation of | 17 |
in the lung and | 17 |
appropriate credit to the | 17 |
rhesus macaque model of | 17 |
transducer and activator of | 17 |
of probable sars cases | 17 |
prognosis in patients with | 17 |
in vitro inhibition of | 17 |
in china clinical characteristics | 17 |
domain of the sars | 17 |
outbreak of pneumonia of | 17 |
risk factors for severe | 17 |
different human organs vulnerable | 17 |
the time of the | 17 |
the national health commission | 17 |
in the united kingdom | 17 |
respiratory syndrome coronavirus infections | 17 |
pneumonia caused by sars | 17 |
o o f journal | 17 |
of novel coronavirus diseases | 17 |
with lopinavir ritonavir or | 17 |
lessons learned from sars | 17 |
the aim of this | 17 |
statutory regulation or exceeds | 17 |
of human coronavirus nl | 17 |
at a dose of | 17 |
first cases of covid | 17 |
a new human coronavirus | 17 |
development of an inactivated | 17 |
respiratory syndrome coronavirus envelope | 17 |
the life cycle of | 17 |
of airborne transmission of | 17 |
disease in china clinical | 17 |
increased risk for covid | 17 |
from different geographical locations | 17 |
and transmission in a | 17 |
one of the main | 17 |
best of our knowledge | 17 |
the spread of this | 17 |
of novel coronavirus infections | 17 |
the gold standard for | 17 |
credit line to the | 17 |
provide a link to | 17 |
the s s cleavage | 17 |
between the two viruses | 17 |
was carried out using | 17 |
also been shown to | 17 |
hek t cells were | 17 |
as part of a | 17 |
at a density of | 17 |
structural and accessory proteins | 17 |
and viral determinants of | 17 |
due to lack of | 17 |
the clinical manifestations of | 17 |
if material is not | 17 |
obtain permission directly from | 17 |
need to obtain permission | 17 |
dashboard to track covid | 17 |
previous studies have shown | 17 |
of the viral infection | 17 |
entry of severe acute | 17 |
approved drug ivermectin inhibits | 17 |
signal transducer and activator | 17 |
the terms of the | 17 |
the performance of the | 17 |
coronavirus of bat origin | 17 |
and the cells were | 17 |
pathogenic human coronavirus infections | 17 |
active site of the | 17 |
is shown in figure | 17 |
the large number of | 17 |
sensitivity and specificity of | 17 |
also found to be | 17 |
admitted to the intensive | 17 |
protective immunity in mice | 17 |
been detected in the | 17 |
the origin and continuing | 17 |
to be a potential | 17 |
compared with bsc alone | 17 |
on the receptor ace | 17 |
rapid spread of the | 17 |
under the terms of | 17 |
line to the material | 17 |
is also important to | 17 |
syndrome a novel coronavirus | 17 |
is not permitted by | 17 |
the amino acid sequence | 17 |
the specificity of the | 17 |
have a higher risk | 17 |
in a study of | 17 |
the case of a | 17 |
is not included in | 17 |
study showed that the | 17 |
of the most important | 17 |
animal models for sars | 17 |
a mouse model for | 17 |
from the onset of | 17 |
origin and continuing evolution | 17 |
causing an outbreak of | 17 |
study clinical features of | 17 |
the fight against covid | 17 |
region of the s | 17 |
of the murine coronavirus | 17 |
of different human organs | 17 |
not permitted by statutory | 17 |
as well as other | 17 |
at a multiplicity of | 17 |
protein of severe acute | 17 |
permission directly from the | 17 |
been reported to have | 17 |
for the spread of | 17 |
the development of an | 17 |
the formation of the | 17 |
to years of age | 17 |
reveals the potential risk | 17 |
in the control group | 17 |
a cluster of cases | 17 |
the spike proteins of | 17 |
in terms of the | 17 |
patients in hong kong | 17 |
patients randomized to ravulizumab | 17 |
of human lung cells | 17 |
results showed that the | 17 |
potential risk of different | 17 |
the ability of the | 17 |
is possible that the | 17 |
terminal domain of the | 17 |
as in the case | 17 |
receptor ace expression reveals | 17 |
from the copyright holder | 17 |
would like to acknowledge | 17 |
causative agent of covid | 17 |
terms of the creative | 17 |
elective hip and knee | 17 |
close contact with a | 17 |
a pandemic by the | 17 |
the onset of illness | 17 |
to obtain permission directly | 17 |
are shown in figure | 17 |
and control of covid | 17 |
syndrome coronavirus envelope protein | 17 |
your intended use is | 17 |
in the united arab | 17 |
official publication of the | 17 |
in a credit line | 17 |
the evolution of sars | 17 |
human organs vulnerable to | 17 |
when compared to the | 17 |
are more susceptible to | 17 |
caused by the sars | 17 |
and immunogenicity of the | 17 |
or exceeds the permitted | 17 |
structural and functional characterization | 17 |
indicate if changes were | 17 |
give appropriate credit to | 17 |
is considered to be | 17 |
otherwise in a credit | 17 |
were found in the | 17 |
material is not included | 17 |
productively infects human gut | 17 |
its interaction with the | 17 |
patients who have recovered | 17 |
a credit line to | 17 |
the receptor ace expression | 17 |
by statutory regulation or | 17 |
use is not permitted | 17 |
receptor and viral determinants | 17 |
exceeds the permitted use | 17 |
remdesivir in adults with | 17 |
seq data analysis on | 17 |
b improves outcome of | 17 |
patients with severe sars | 17 |
the virus and the | 17 |
to the viral infection | 17 |
washed three times with | 17 |
design and development of | 17 |
infection in a nonhuman | 17 |
specific antibody responses in | 17 |
as the number of | 17 |
and influenza a virus | 17 |
m z value of | 17 |
both cd and cd | 17 |
intended use is not | 17 |
the best of our | 17 |
study of hydroxychloroquine in | 17 |
of the coronaviridae family | 17 |
the possibility of a | 17 |
if changes were made | 17 |
igg and igm antibodies | 17 |
directly from the copyright | 17 |
adaptation to human ace | 17 |
and it has been | 17 |
the emergence of a | 17 |
found to be more | 17 |
features and clinical course | 17 |
based dashboard to track | 17 |
from person to person | 17 |
analysis on the receptor | 17 |
even in the absence | 17 |
and your intended use | 17 |
that the virus is | 17 |
infects human gut enterocytes | 17 |
a newly discovered coronavirus | 17 |
the united states and | 17 |
with the human ace | 17 |
and activator of transcription | 17 |
with the severe acute | 17 |
cutaneous manifestations in covid | 17 |
regulation or exceeds the | 17 |
of the epidemic in | 17 |
patients with confirmed sars | 17 |
and indicate if changes | 17 |
h n influenza virus | 17 |
o f journal pre | 17 |
of thrombotic complications in | 17 |
you will need to | 17 |
for their ability to | 17 |
risk of different human | 17 |
upper respiratory tract infections | 17 |
of type i interferons | 17 |
from the respiratory tract | 17 |
an urgent need to | 17 |
coronavirus infection in the | 17 |
will need to obtain | 17 |
and central nervous system | 17 |
have not yet been | 17 |
is an open access | 17 |
for the study of | 17 |
of human neutralizing antibodies | 17 |
the novel coronavirus outbreak | 17 |
emergence of a novel | 17 |
is part of the | 17 |
imbalanced host response to | 17 |
the n k mutation | 16 |
divergence of coronavirus spike | 16 |
predict potential intermediate hosts | 16 |
in the pathophysiology of | 16 |
epidemiological and clinical features | 16 |
coronavirus spike proteins and | 16 |
cells together with innate | 16 |
characteristics of an outbreak | 16 |
are based on the | 16 |
and viral load analysis | 16 |
cell entry mechanisms of | 16 |
spike proteins and host | 16 |
complications in critically ill | 16 |
the development of therapeutic | 16 |
susceptibility to the antiviral | 16 |
binding site of sars | 16 |
observed in patients with | 16 |
have no competing interests | 16 |
be the key to | 16 |
patients with mild covid | 16 |
of acute lung injury | 16 |
and transmission of sars | 16 |
of smell or taste | 16 |
an open access article | 16 |
indicated otherwise in a | 16 |
coronavirus infection causes neuronal | 16 |
be taken into account | 16 |
to the best of | 16 |
coronavirus adaptation to human | 16 |
are susceptible to sars | 16 |
immune responses in covid | 16 |
syndrome coronavirus as a | 16 |
reported in this paper | 16 |
respiratory syndrome coronavirus c | 16 |
and the proofreading exoribonuclease | 16 |
a short period of | 16 |
play a crucial role | 16 |
the j o u | 16 |
detection of sars coronavirus | 16 |
used to determine the | 16 |
epidemiologic features and clinical | 16 |
causes neuronal death in | 16 |
viral and cellular membranes | 16 |
reverse transcriptase polymerase chain | 16 |
ill icu patients with | 16 |
coronavirus spike protein is | 16 |
an inactivated vaccine candidate | 16 |
it is unclear whether | 16 |
parameters are associated with | 16 |
the transmembrane serine protease | 16 |
activity in vitro and | 16 |
their inactivation with biocidal | 16 |
the hr domain of | 16 |
and divergence of coronavirus | 16 |
entry factors are highly | 16 |
the ability of sars | 16 |
drugs for the treatment | 16 |
antibodies elicited by sars | 16 |
viral determinants of sars | 16 |
of the complement system | 16 |
functional characterization of the | 16 |
by a combination of | 16 |
cases of coronavirus disease | 16 |
the effect of the | 16 |
organ infection and the | 16 |
was added to each | 16 |
an outbreak of novel | 16 |
commercial or financial relationships | 16 |
of the severity of | 16 |
in close proximity to | 16 |
coronavirus spike protein for | 16 |
be used for the | 16 |
enteric involvement of coronaviruses | 16 |
at high risk of | 16 |
to the antiviral remdesivir | 16 |
critically ill icu patients | 16 |
to play a role | 16 |
of convalescent plasma and | 16 |
ace receptors predict potential | 16 |
encephalitis in mice transgenic | 16 |
informed consent was obtained | 16 |
of encephalitis in mice | 16 |
epithelial cells together with | 16 |
it is clear that | 16 |
over the course of | 16 |
the activity of the | 16 |
the sars epidemic in | 16 |
consistent detection of novel | 16 |
shed light on the | 16 |
host ace receptors predict | 16 |
a potential route of | 16 |
dromedary camels in saudi | 16 |
factors are highly expressed | 16 |
human neutralizing monoclonal antibodies | 16 |
of the upper respiratory | 16 |
increases the risk of | 16 |
and biological evaluation of | 16 |
and t cell responses | 16 |
death in the absence | 16 |
credit to the original | 16 |
detect the presence of | 16 |
chloroquine for the treatment | 16 |
the trinity of covid | 16 |
multiple organ infection and | 16 |
days from symptom onset | 16 |
influenza a and b | 16 |
and the need for | 16 |
link to the creative | 16 |
transmission in a skilled | 16 |
animal model for sars | 16 |
the inhibition of the | 16 |
the global initiative on | 16 |
hr and hr domains | 16 |
this article are included | 16 |
been proposed as a | 16 |
in the detection of | 16 |
on the role of | 16 |
the crystal structures of | 16 |
can be divided into | 16 |
with severe coronavirus disease | 16 |
and the united states | 16 |
in the upper and | 16 |
virus targeting the cns | 16 |
the intermediate host of | 16 |
the risk of transmission | 16 |
the prevention and control | 16 |
not appear to be | 16 |
poor prognosis in patients | 16 |
manifestations in patients with | 16 |
first wave of the | 16 |
against the novel coronavirus | 16 |
surfaces and their inactivation | 16 |
d g increases infectivity | 16 |
the cytokine release syndrome | 16 |
of hydroxychloroquine and chloroquine | 16 |
is located in the | 16 |
the first line of | 16 |
proteins and host ace | 16 |
of these viruses in | 16 |
novel coronavirus in saliva | 16 |
of a novel human | 16 |
human transmission of mers | 16 |
infection causes neuronal death | 16 |
study protocol for a | 16 |
china a novel coronavirus | 16 |
detection of antibodies against | 16 |
hypertension and diabetes mellitus | 16 |
quantitative detection and viral | 16 |
the clinical characteristics of | 16 |
type i interferon and | 16 |
infection and the pathogenesis | 16 |
camels in saudi arabia | 16 |
to be infected with | 16 |
identification of severe acute | 16 |
syndrome coronavirus in dromedary | 16 |
avian infectious bronchitis virus | 16 |
to gain entry into | 16 |
antibodies in patients with | 16 |
syndrome coronavirus infection causes | 16 |
of s protein to | 16 |
type i and iii | 16 |
in critically ill icu | 16 |
of igm and igg | 16 |
inanimate surfaces and their | 16 |
the development of effective | 16 |
viral polymerase and the | 16 |
financial relationships that could | 16 |
you give appropriate credit | 16 |
and functional characterization of | 16 |
of the olfactory epithelium | 16 |
in comparison to the | 16 |
of the outbreak in | 16 |
thrombotic complications in critically | 16 |
written informed consent was | 16 |
on the development of | 16 |
a vaccine against sars | 16 |
for binding to the | 16 |
aerodynamic analysis of sars | 16 |
named severe acute respiratory | 16 |
or financial relationships that | 16 |
for a long time | 16 |
in a cohort of | 16 |
epidemiological characteristics of an | 16 |
potential inhibitors of sars | 16 |
china a pneumonia outbreak | 16 |
the lungs of sars | 16 |
transgenic for human ace | 16 |
the putative receptor of | 16 |
in severe coronavirus disease | 16 |
together with innate immune | 16 |
coagulation parameters are associated | 16 |
the release of the | 16 |
the virus that causes | 16 |
of the small intestine | 16 |
open access article distributed | 16 |
in an animal model | 16 |
to the original author | 16 |
on the spike protein | 16 |
a potential conflict of | 16 |
polymerase and the proofreading | 16 |
is a class i | 16 |
the genomes of sars | 16 |
highly sensitive and specific | 16 |
and pathogenesis of sars | 16 |
morbidity and mortality in | 16 |
course of patients infected | 16 |
it is reasonable to | 16 |
entry mechanisms of sars | 16 |
the sensitivity and specificity | 16 |
were identified in the | 16 |
and the middle east | 16 |
are known to cause | 16 |
virus entry into the | 16 |
humoral and cellular immunity | 16 |